The International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly) have come together for the second phase of the Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2), reaffirming their commitment to helping people with diabetes effectively manage their condition.

BRIDGES 2 will build upon the work undertaken and the lessons learned during the initial phase of the programme which operated from 2007 to 2015. The programme will fund and replicate a selection of three projects from the initial phase, placing an emphasis on the secondary prevention of diabetes and a strong involvement of local public health authorities.

The aim of this second round of the BRIDGES programme is to replicate in low-and-middle income countries, one of the three successful interventions which took place in Mali (Africa), Egypt (Middle East and North Africa) and China (Western Pacific).

Second call for applications

The grant application form available for download below serves as a call for tender for replication or expansion of one of the three selected interventions from the previous round of the BRIDGES programme that have proven to be successful in one country, to be reproduced and implemented elsewhere.

Applicants will need to explain how they will adapt the chosen interventions culturally and socially to its new context, demonstrate strong support for their project from local authorities and describe the long term sustainability of their project.

IDF will provide financial and mentoring support to the selected applicants to ensure the successful replication of the intervention. The role, engagement, and commitment of local authorities will be key in the selection process. Prior to the start of the intervention, the selected applicants will receive onsite training by the Principal Investigators of the original intervention , as well as ongoing mentoring and support.

The submission deadline for applications is Februay 26, 2018, 0:00 CET.


First call for applications

A call for applications  for replication or expansion of one of the three selected interventions from the previous round of the BRIDGES programme that have proven to be successful in one country, was conducted in June-August 2017. All grant proposals were peer reviewed and prioritised by a cross-disciplinary external review group under the coordination of IDF. The following three institutions have been selected as implementation sites:

Each of the three institutions will receive funding and the adequate mentorship to implement a tailor-made diabetes secondary prevention programme. This will enable the implementation of established evidenced-based interventions and community oriented approaches to diabetes care in different settings, with the ultimate aim of improving health outcomes for people living with diabetes.

The selected projects are varied and include:

  • A randomized trial on the suitability of peer education to improve diabetes management and outcomes in a low-income setting (Banda Aceh, Indonesia)
  • A randomized trial on an intensive education intervention using a mobile application and network of people living with diabetes to implement glycaemic control (Delta State, Nigeria)
  • A community-based randomized trial and lifestyle intervention using a targeted shared care approach on pregnancy outcomes in Nigerian women with gestational diabetes but without diabetes (Nsukka, Nigeria).

The principal investigators of the projects from the first round of BRIDGES will supervise and provide mentorship to the implementation of the selected projects throughout their duration. Field visits will be organized and onsite workshops will take place in each site. The workshops will be supervised by the BRIDGES 2 Steering group, comprised of international experts, and intensive monitoring of each project will be carried out throughout the implementation phase.

For more information about BRIDGES 2, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

© 2020 International Diabetes Federation Disclaimer Privacy policy